Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human Microbiota and Breast Cancer—Is There Any Relevant Link?—A Literature Review and New Horizons Toward Personalised Medicine
Diogo Alpuim Costa, José Guilherme Nobre, Marta Vaz Batista, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

Intratumoural microbiota: a new frontier in cancer development and therapy
Yaqi Cao, Hui Xia, Xueyun Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 69
Estrogens and the risk of breast cancer: A narrative review of literature
Khayry Al‐Shami, Sajeda Awadi, Almu’atasim Khamees, et al.
Heliyon (2023) Vol. 9, Iss. 9, pp. e20224-e20224
Open Access | Times Cited: 51
Microbial Therapy and Breast Cancer Management: Exploring Mechanisms, Clinical Efficacy, and Integration within the One Health Approach
Charalampos Filippou, Sophia Themistocleous, Giorgos Marangos, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1110-1110
Open Access | Times Cited: 18
Advancements in 3D Cell Culture Systems for Personalizing Anti-Cancer Therapies
Andrew M. K. Law, Laura Rodríguez de la Fuente, Thomas J. Grundy, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 67
The Gut Microbiome and Female Health
Ruqaiyyah Siddiqui, Zinb Makhlouf, Ahmad M. Alharbi, et al.
Biology (2022) Vol. 11, Iss. 11, pp. 1683-1683
Open Access | Times Cited: 46
Molecular Mechanisms of Western Diet-Induced Obesity and Obesity-Related Carcinogenesis—A Narrative Review
Dhruvi Lathigara, Devesh Kaushal, Robert Wilson
Metabolites (2023) Vol. 13, Iss. 5, pp. 675-675
Open Access | Times Cited: 33
Functional biotransformation of phytoestrogens by gut microbiota with impact on cancer treatment
Esma Karahmet Farhat, Emina Karahmet Sher, Amina Džidić-Krivić, et al.
The Journal of Nutritional Biochemistry (2023) Vol. 118, pp. 109368-109368
Open Access | Times Cited: 30
Acupuncture ameliorates breast cancer-related fatigue by regulating the gut microbiota-gut-brain axis
Zhuan Lv, Ruidong Liu, Kaiqi Su, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 35
Human Microbiota and Immunotherapy in Breast Cancer - A Review of Recent Developments
Marina Vitorino, Susana Baptista de Almeida, Diogo Alpuim Costa, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 30
The role of gut microbial β-glucuronidase in drug disposition and development
Song Gao, Rongjin Sun, Rashim Singh, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 10, pp. 103316-103316
Open Access | Times Cited: 30
Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer
Rama Rao Malla, Rakshmitha Marni, Seema Kumari, et al.
Clinical Breast Cancer (2021) Vol. 22, Iss. 3, pp. 200-211
Closed Access | Times Cited: 38
How the Gut Microbiome Links to Menopause and Obesity, with Possible Implications for Endometrial Cancer Development
Malou P. H. Schreurs, Peggy J. de Vos van Steenwijk, Andrea Romano, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 13, pp. 2916-2916
Open Access | Times Cited: 33
The conundrum of breast cancer and microbiome - A comprehensive review of the current evidence
Andri Papakonstantinou, Paolo Nucíforo, María Borrell, et al.
Cancer Treatment Reviews (2022) Vol. 111, pp. 102470-102470
Closed Access | Times Cited: 26
Metagenomic Analyses Reveal Distinct Gut Microbiota Signature for Predicting the Neoadjuvant Chemotherapy Responsiveness in Breast Cancer Patients
Yuanyuan Li, Bingbin Dong, Wei Wu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 24
Immune checkpoint inhibitors in breast cancer: development, mechanisms of resistance and potential management strategies
Rachel SJ Wong, Rebecca JM Ong, Joline SJ Lim
Cancer Drug Resistance (2023) Vol. 6, Iss. 4, pp. 768-87
Open Access | Times Cited: 16
Breast Cancer Survivors and Healthy Women: Could Gut Microbiota Make a Difference?—“BiotaCancerSurvivors”: A Case-Control Study
T. Caleça, Pedro Ribeiro, Marina Vitorino, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 594-594
Open Access | Times Cited: 15
Endocrine Disruptors in Food, Estrobolome and Breast Cancer
Alessio Filippone, Cristina Rossi, Maria Maddalena Rossi, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3158-3158
Open Access | Times Cited: 14
The RIG-I-like receptor signaling pathway triggered by Staphylococcus aureus promotes breast cancer metastasis
Haile Zhao, Linzhe Zhang, Dongdong Du, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113195-113195
Closed Access | Times Cited: 5
Novel perspectives on the link between obesity and cancer risk: from mechanisms to clinical implications
Xiaoye Shi, Aimin Jiang, Zhengang Qiu, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 6, pp. 945-968
Closed Access | Times Cited: 5
Bacteria and tumor: Understanding the roles of bacteria in tumor genesis and immunology
Mingming Zhao, Xiaoxuan Chen, Zhenghao Yang, et al.
Microbiological Research (2022) Vol. 261, pp. 127082-127082
Open Access | Times Cited: 20
Natural products derived from medicinal plants and microbes might act as a game-changer in breast cancer: a comprehensive review of preclinical and clinical studies
Rajeev K. Singla, Xiaoyan Wang, Rohit Gundamaraju, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 33, pp. 11880-11924
Closed Access | Times Cited: 20
Local Breast Microbiota: A “New” Player on the Block
Marina Vitorino, Diogo Alpuim Costa, Rodrigo Vicente, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3811-3811
Open Access | Times Cited: 19
The Role of Obesity in Breast Cancer Pathogenesis
Ira Glassman, Nghia Le, Aamna Asif, et al.
Cells (2023) Vol. 12, Iss. 16, pp. 2061-2061
Open Access | Times Cited: 12
Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancer
Maximilian Marhold, Simon Udovica, A. Halstead, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Obesity, dysbiosis and inflammation: interactions that modulate the efficacy of immunotherapy
Ashutosh S. Yende, Dipali Sharma
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top